ArticleBioengineering (Basel, Switzerland)2026
An Effective and Interpretable EEG-Based Depression Recognition Method Using Hybrid Feature Selection.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Recent studies on EEG-based automated depression detection have primarily depended on complex deep learning models. While these methods improve classification performance, their practical application is limited by high computational complexity, challenging training processes, and poor interpretability. This paper proposes an efficient method for depression recognition, which extracts multi-domain features from preprocessed EEG signals and selects the most discriminative feature subset by integrating the rapid preliminary screening capability of RankSearch with the interactive optimization ability of the Genetic Algorithm (GA). Our approach first eliminates redundant features efficiently through RankSearch, then deeply explores inter-feature relationships via GA, significantly enhancing classification performance while maintaining feature-level interpretability. Using the optimized feature subset, we evaluate performance with multiple machine learning classifiers (Decision Tree, KNN, Random Forest, SVM, XGBoost). Experiments on the public HUSM dataset demonstrate superior performance under rigorous cross-validation (accuracy = 95.08%, sensitivity = 95.99%, specificity = 94.30%, F1-score = 95%, AUC = 0.9514), with feature importance analysis further confirming interpretability. Compared to existing models, our method achieves lower computational complexity and higher clinical practicality, offering a more efficient technical solution for objective depression diagnosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.